Minimal Residual Disease (mrd) - Histology

Relevant Publications

CoHIT: a one-pot ultrasensitive ERA-CRISPR system for detecting multiple same-site indels.

Issue Release: 2024

Detection of minimal residual disease in acute myeloid leukemia: evaluating utility and challenges.

Issue Release: 2024

Recommendations for the Management of Patients with Hairy-Cell Leukemia and Hairy-Cell Leukemia-like Disorders: A Work by French-Speaking Experts and French Innovative Leukemia Organization (FILO) Group.

Issue Release: 2024

Prediction of Response to FDA-Approved Targeted Therapy and Immunotherapy in Acute Lymphoblastic Leukemia (ALL).

Issue Release: 2024

Ponatinib as a Prophylactic or Pre-Emptive Strategy to Prevent Cytological Relapse after Allogeneic Stem Cell Transplantation in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Transplanted in Complete Cytological Remission.

Issue Release: 2024

Real-world evidence on treatment pattern, effectiveness, and safety of blinatumomab in Chinese patients with B-cell acute lymphoblastic leukemia.

Issue Release: 2024

Response adaptive salvage treatment with daratumumab-lenalidomide-dexamethasone for newly diagnosed transplant-eligible multiple myeloma patients failing front-line bortezomib-based induction therapy-ALLG MM21.

Issue Release: 2024

Measurable Residual Disease Analysis by Flow Cytometry and Correlation With Molecular Measurable Residual Disease in Acute Promyelocytic Leukemia: A Real-World Prospective Study.

Issue Release: 2024

Flow cytometric minimal residual disease measurement accounting for cytogenetics in children with non-high-risk acute lymphoblastic leukemia treated according to the ALL-MB 2008 protocol.

Issue Release: 2024

Combination of venetoclax and azacitidine in relapsed/refractory acute B-cell lymphoblastic leukemia: a case series from a single center.

Issue Release: 2024

Linkage of cell division cycle 42 with clinical features, treatment response and survival in adult Philadelphia chromosome negative acute lymphoblastic leukemia.

Issue Release: 2024

SOHO State of the Art Updates and Next Questions: Pre-emptive Therapy at Molecular Measurable Residual Disease Failure in Acute Myeloid Leukemia.

Issue Release: 2024

FLT3-Mutated Leukemic Stem Cells: Mechanisms of Resistance and New Therapeutic Targets.

Issue Release: 2024

Minimal Residual Disease Status in Multiple Myeloma 1 Year After Autologous Hematopoietic Cell Transplantation and Lenalidomide Maintenance Are Associated With Long-Term Overall Survival.

Issue Release: 2024

Comprehensive analysis of the efficacy and safety of CAR T-cell therapy in patients with relapsed or refractory B-cell acute lymphoblastic leukaemia: a systematic review and meta-analysis.

Issue Release: 2024

Survival after allogeneic transplantation according to pretransplant minimal residual disease and conditioning intensity in patients with acute myeloid leukemia.

Issue Release: 2024

Baseline circulating tumor DNA predicts long-term survival outcomes for patients with early breast cancer.

Issue Release: 2024

Intensified conditioning regimens with total marrow irradiation/etoposide/cyclophosphamide and busulfan/etoposide/cyclophosphamide overcome the impact of pre-transplant minimal residual disease on outcomes in high-risk acute lymphoblastic leukemia patients in complete remission.

Issue Release: 2024

Critical Factors in the Analytical Work Flow of Circulating Tumor DNA-Based Molecular Profiling.

Issue Release: 2024

Early Detection of Molecular Residual Disease and Risk Stratification for Children with Acute Myeloid Leukemia via Circulating Tumor DNA.

Issue Release: 2024

Why Are Biofilms Clinically Significant?

What Histological Changes are Observed in Common Pulmonary Diseases?

How to Access a Histology Core Facility?

What is Renal Parenchymal Disease?

How are Epithelioid Cells Identified in Histology?

What documentation is required in histology laboratories?

How Are Epithelial Cells Affected?

What is No Staining in Histology?

How Can AWS Help in Data Storage?

What are Some Examples of Signaling Pathways?

Minimal Residual Disease (mrd) - Histology

Relevant Publications

Partnered Content Networks

Relevant Topics